Mechanism of Action
Lutein integrates into retinal cell membranes thanks to its lipophilic properties (fat affinity). Once in place, its conjugated double bonds absorb blue light photons before they reach the visual cells. In parallel, it neutralizes reactive oxygen species (free radicals produced by light exposure) within retinal tissues.
This dual role of optical filtration and antioxidant defense limits the accumulation of damage in the macula over decades. Lutein absorption is enhanced by the presence of dietary lipids. Taking it with a fat-containing meal promotes its passage into the bloodstream and subsequent deposition in target tissues.
Key Benefits
- Strong
The AREDS2 study, conducted on over 4,000 participants for five years, demonstrated the efficacy of the lutein and zeaxanthin combination for macular health. This duo replaced beta-carotene in the reference formulation.
- Strong
Multiple meta-analyses confirm that supplementation at 10 mg per day significantly increases macular pigment optical density (MPOD), a measurable marker of retinal protection.
- Moderate
Controlled trials report improved contrast sensitivity and glare recovery in adults supplemented with lutein for 6 to 12 months.
- Moderate
Lutein reduces oxidative stress markers in retinal tissues exposed to blue light, according to clinical trials measuring photochemical damage before and after supplementation.
- Emerging
Preliminary human data associate higher serum lutein concentrations with better cognitive performance in older adults. Research on this topic remains active.
Dosage & Forms
Lutein exists in free or esterified form. Free lutein does not require enzymatic hydrolysis (breakdown by digestive enzymes) in the gut. It is directly absorbable, making it more bioavailable than lutein esters.
Singular uses free lutein extracted from Tagetes erecta flowers, at a dose of 10 mg per day. Major clinical studies (notably AREDS2) used the same dose, at which significant increases in macular pigment optical density are observed. Dosages below 6 mg show less reproducible effects. Above 20 mg, additional benefit data are limited.
Co-administration with zeaxanthin replicates the natural ratio found in human macular pigment.
In the Singular Formula
Inclusion rationale
Carotenoid of the xanthophyll family, extracted from marigold petals (Tagetes erecta). Lutein naturally concentrates in the macula of the retina, at the periphery of the fovea, where together with zeaxanthin (present in the formula and concentrated at the center of the fovea) it constitutes the macular pigment. This pigment is the eye's natural optical filter: it selectively absorbs high-energy blue light (400-500 nm), protecting photoreceptors from cumulative photochemical damage. In a context of increasing exposure to digital screens and LED lighting, the daily blue light load has risen considerably, reinforcing interest in the macular pigment. The optical density of the macular pigment (MPOD) varies according to dietary intake of lutein and zeaxanthin. This parameter is measurable by non-invasive techniques and correlated with long-term retinal health. Astaxanthin (also present in the formula) complements this carotenoid protection through its action at the cell membrane level. The body does not synthesize lutein: it must be provided through diet or supplementation.
Selected form
Lutein extracted from Calendula officinalis (marigold) flowers, through a preservative-free water-ethanol process. Lutein is a carotenoid of the xanthophyll family. It naturally concentrates in the macula, the central area of the retina responsible for fine vision. Unlike carotenoids such as beta-carotene, lutein is not synthesised by the human body: it must be obtained from the diet. Extraction from the whole flower preserves the natural carotenoid profile. Quality: vegan, non-GMO, pesticide-free, preservative-free, Halal and Kosher certified.
Formula dosage
0 to 10 mg.
Synergies in the formula
Safety & Precautions
Lutein has an excellent safety track record. The AREDS2 study, conducted on over 4,000 participants for five years, reported no significant adverse effects at 10 mg per day. Doses up to 20 mg daily are well tolerated in clinical literature.
No major drug interactions are documented. Lutein is a fat-soluble nutrient, but unlike retinol (preformed vitamin A), it does not carry a risk of hypervitaminosis at nutritional doses.
Supplementation is not recommended for smokers at very high doses (above 20 mg per day) as a precautionary measure, by analogy with beta-carotene data. During pregnancy, breastfeeding, or when taking medication, prior medical advice is recommended.
Scientific Studies
| Authors | Year | Type | Journal | |
|---|---|---|---|---|
| Ma L et al. | 2012 | Meta-analysis | British Journal of Nutrition | View on PubMed |
Lutein and zeaxanthin intake and the risk of age-related macular degeneration: a systematic review and meta-analysis Meta-analysis of six prospective studies showing that high lutein and zeaxanthin intake is significantly associated with reduced risk of advanced age-related macular degeneration. | ||||
| Age-Related Eye Disease Study 2 Research Group | 2013 | Randomised Controlled Trial | JAMA | View on PubMed |
Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial Randomized trial on over 4,000 participants showing that lutein and zeaxanthin are a safe and effective alternative to beta-carotene in the AREDS formulation. | ||||
| Bernstein PS et al. | 2016 | Systematic Review | Progress in Retinal and Eye Research | View on PubMed |
Lutein, zeaxanthin, and meso-zeaxanthin: The basic and clinical science underlying carotenoid-based nutritional interventions against ocular disease Comprehensive review of the biochemical mechanisms and clinical evidence supporting the use of macular carotenoids in supplementation for ocular health. | ||||
| Ranard KM et al. | 2017 | Systematic Review | European Journal of Nutrition | View on PubMed |
Dietary guidance for lutein: consideration for intake recommendations is scientifically supported Review of the evidence supporting lutein intake recommendations, including levels associated with measurable benefits on macular pigment density. | ||||
| Evans JR, Lawrenson JG | 2023 | Systematic Review | Cochrane Database of Systematic Reviews | View on PubMed |
Antioxidant vitamin and mineral supplements for slowing the progression of age-related macular degeneration Cochrane systematic review evaluating the effect of antioxidant supplements (including lutein) on macular degeneration progression. Confirms the benefit of the AREDS2 formulation. | ||||